An anonymous director reports

MEDIPHARM LABS SETS DATE TO REPORT FIRST QUARTER 2023 FINANCIAL RESULTS

Medipharm Labs Corp. will release its first quarter financial results for the three-month period ended March 31, 2023, before markets open on Monday, May 15, 2023.

Medipharm Labs' executive management team will also host a conference call and audio webcast on Monday, May 15, 2023, at 8:30 a.m. Eastern Time, to discuss the company's financial results.

Audio conference call dial-in details

Toll-free number:  1-888-330-2454

International number:  1-240-789-2714

Conference ID:  4921762

Participants are asked to dial in approximately 15 minutes before the start of the call.

Audio webcast

An audio webcast will be available.

For those who are unable to participate on the live conference call or webcast, a replay will be available approximately one day after completion of the call.

About Medipharm Labs Corp.

Founded in 2015, Medipharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a good manufacturing practice certified facility with ISO standard-built clean rooms. Medipharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, Medipharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets.

In 2021, Medipharm Labs received a pharmaceutical drug establishment licence from Health Canada, becoming the only company in North America to hold a domestic good manufacturing licence for the extraction of natural cannabinoids. The company carries out its operations in compliance with all applicable laws in the countries in which it operates.

We seek Safe Harbor.